Myeloid-specific disruption of recombination signal binding protein Jκ ameliorates hepatic fibrosis by attenuating inflammation through cylindromatosis in mice

Hepatology

Volumn 61, Issue 1, 2015, Pages 303-314

  He, Fei ^a   Guo, Feng Cheng ^a   Li, Zhi ^b   Yu, Heng Chao ^a   Ma, Peng Fei ^a   Zhao, Jun Long ^b   Feng, Lei ^b   Li, Wei Na ^b   Liu, Xiao Wei ^b   Qin, Hong Yan ^b   Dou, Ke Feng ^a   Han, Hua ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE BINDING PROTEIN; NOTCH RECEPTOR; PLATELET DERIVED GROWTH FACTOR B; SYNAPTOTAGMIN I; TRANSFORMING GROWTH FACTOR BETA1; CYLD PROTEIN, MOUSE; CYLINDROMATOSIS PROTEIN, MOUSE; CYSTEINE PROTEINASE; RBPJ PROTEIN, MOUSE; TUMOR SUPPRESSOR PROTEIN;

ADENOID CYSTIC CARCINOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE OVEREXPRESSION; HEPATITIS; INFLAMMATORY CELL; LIVER BIOPSY; LIVER FIBROSIS; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STELLATE CELL; UPREGULATION; ANIMAL; C57BL MOUSE; CELL CULTURE; IMMUNOLOGY; KNOCKOUT MOUSE; LIVER CIRRHOSIS; METABOLISM; PHYSIOLOGY;

ANIMALS; CELLS, CULTURED; CYSTEINE ENDOPEPTIDASES; HEPATIC STELLATE CELLS; HEPATITIS; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE-BINDING PROTEIN; LIVER CIRRHOSIS; MACROPHAGES; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 84920945857     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27394     Document Type: Article

References (37)

1. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005;115:209-218.
2. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008;134:1655-1669.
3. Wynn TA, Barron L. Macrophages: master regulators of inflammation and fibrosis. Sem Liver Dis 2010;30:245-257.
4. Duffield JS, Forbes SJ, Constandinou CM, Clay S, Partolina M, Vuthoori A, et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 2005;115:56-65.
5. Wang J, Leclercq I, Brymora JM, Xu N, Ramezani-Moghadam M, London RM, et al. Kupffer cells mediate leptin-induced liver fibrosis. Gastroenterology 2009;137:713-723.
6. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. J Clin Invest 1998;101:890-898.
7. Weng HL, Liu Y, Chen JL, Huang T, Xu LJ, Godoy P, et al. The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin-13 as driving forces in fibrogenesis. Hepatology 2009;50:230-243.
8. Fallowfield JA, Mizuno M, Kendall TJ, Constandinou CM, Benyon RC, Duffield JS, et al. Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J Immunol 2007;178:5288-5295.
9. Uchinami H, Seki E, Brenner DA, D'Armiento J. Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis. Hepatology 2006;44:420-429.
10. Henderson NC, Iredale JP. Liver fibrosis: cellular mechanisms of progression and resolution. Clin Sci 2007;112:265-280.
11. Wang YC, He F, Feng F, Liu XW, Dong GY, Qin HY, et al. Notch signaling determines the M1 versus M2 polarization of macrophages in antitumor immune responses. Cancer Res 2010;70:4840-4849.
12. Zhang W, Xu W, Xiong S. Blockade of Notch1 signaling alleviates murine lupus via blunting macrophage activation and M2b polarization. J Immunol 2010;184:6465-6478.
13. Xu H, Zhu J, Smith S, Foldi J, Zhao B, Chung AY, et al. Notch-RBP-J signaling regulates the transcription factor IRF8 to promote inflammatory macrophage polarization. Nat Immunol 2012;13:642-650.
14. Monsalve E, Ruiz-García A, Baladrón V, Ruiz-Hidalgo MJ, Sánchez-Solana B, Rivero S, et al. Notch1 upregulates LPS-induced macrophage activation by increasing NF-kappaB activity. Eur J Immunol 2009;39:2556-2570.
15. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science 1999;284:770-776.
16. Han H, Tanigaki K, Yamamoto N, Kuroda K, Yoshimoto M, Nakahata T, et al. Inducible gene knockout of transcription factor recombination signal binding protein-J reveals its essential role in T versus B lineage decision. Int Immunol 2002;14:637-645.
17. Gäbele E, Froh M, Arteel GE, Uesugi T, Hellerbrand C, Schölmerich J, et al. TNFalpha is required for cholestasis-induced liver fibrosis in the mouse. Biochem Biophys Res Commun 2009;378:348-353.
18. Liu W, Hou Y, Chen H, Wei H, Lin W, Li J, et al. Sample preparation method for isolation of single-cell types from mouse liver for proteomic studies. Proteomics 2011;11:3556-3564.
19. Qin H, Wang J, Liang Y, Taniguchi Y, Tanigaki K, Han H. RING1 inhibits transactivation of RBP-J by Notch through interaction with LIM protein KyoT2. Nucleic Acids Res 2004;32:1492-1501.
20. Espinosa L, Inglés-Esteve J, Robert-Moreno A, Bigas A. IkappaBalpha and p65 regulate the cytoplasmic shuttling of nuclear corepressors: cross-talk between Notch and NFkappaB pathways. Mol Biol Cell 2003;14:491-502.
21. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Förster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res 1999;8:265-277.
22. Zhao B, Grimes SN, Li S, Hu X, Ivashkiv LB. TNF-induced osteoclastogenesis and inflammatory bone resorption are inhibited by transcription factor RBP-J. J Exp Med 2012;209:319-334.
23. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004;25:677-686.
24. Espinosa L, Cathelin S, D'Altri T, Trimarchi T, Statnikov A, Guiu J, et al. The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemia. Cancer Cell 2010;18:268-281.
25. D'Altri T, Gonzalez J, Aifantis I, Espinosa L, Bigas A. Hes1 expression and CYLD repression are essential events downstream of Notch1 in T-cell leukemia. Cell Cycle 2011;10:1031-1036.
26. Massoumi R. Ubiquitin chain cleavage: CYLD at work. Trends Biochem Sci 2010;35:392-399.
27. Saito JM, Bostick MK, Campe CB, Xu J, Maher JJ. Infiltrating neutrophils in bile duct-ligated livers do not promote hepatic fibrosis. Hepatol Res 2003;25:180-191.
28. Reiley WW, Jin W, Lee AJ, Wright A, Wu X, Tewalt EF, et al. Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses. J Exp Med 2007;204:1475-1485.
29. Symons A, Beinke S, Ley SC. MAP kinase kinase kinases and innate immunity. Trends Immunol 2006;27:40-48.
30. Pannem RR, Dorn C, Hellerbrand C, Massoumi R. Cylindromatosis gene CYLD regulates hepatocyte growth factor expression in hepatic stellate cells through interaction with histone deacetylase 7. Hepatology 2014;60:1066-1081.
31. Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999;18:6853-6866.
32. Khachigian LM, Resnick N, Gimbrone MA Jr, Collins T. Nuclear factor-kappa B interacts functionally with the platelet-derived growth factor B-chain shear-stress response element in vascular endothelial cells exposed to fluid shear stress. J Clin Invest 1995;96:1169-1175.
33. Roberts AB, Kim SJ, Kondaiah P, Jakowlew SB, Denhez F, Glick AB, et al. Transcriptional control of expression of the TGF-betas. Ann N Y Acad Sci 1990;593:43-50.
34. Kim SJ, Angel P, Lafyatis R, Hattori K, Kim KY, Sporn MB, et al. Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex. Mol Cell Biol 1990;10:1492-1497.
35. Xie G, Karaca G, Swiderska-Syn M, Michelotti GA, Krüger L, Chen Y, et al. Cross-talk between Notch and Hedgehog regulates hepatic stellate cell fate in mice. Hepatology 2013;58:1801-1813.
36. Yu HC, Qin HY, He F, Wang L, Fu W, Liu D, et al. Canonical Notch pathway protects hepatocytes from ischemia reperfusion injury by repressing ROS production through JAK2/STAT3 signaling. Hepatology 2011;54:979-988.
37. Chen Y, Zheng S, Qi D, Zheng S, Guo J, Zhang S, et al. Inhibition of Notch signaling by a g-secretase inhibitor attenuates hepatic fibrosis in rats. PLoS One 2012;7:e46512.